LIQUIDIA CORPORATION Cash
LIQUIDIA CORPORATION (LQDA) had Cash of $65.30 million as of 2020-12-31, per its 10-Q filed 2021-11-03.
Discontinued › Balance Sheet › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-11-03
- 2020-12-31: Cash $65.30M; Cash as first filed $65.32M.
- 2019-12-31: Cash $55.80M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2020-12-31 | $65.30M 10-Q · filed 2021-11-03 | $65.32M 10-K · filed 2021-03-25 |
| 2019-12-31 | $55.80M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |